K.Y. Westerhout

Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany

K.Y. Westerhout, B.G. Verheggen, C.H. Schreder et al. · Journal of Medical Economics · 2012 · 46 citations · Full text

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass‐allergic rhinoconjunctivitis in Germany

B.G. Verheggen, K.Y. Westerhout, C.H. Schreder et al. · Clinical and Translational Allergy · 2015 · 38 citations · Full text

A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service

K.Y. Westerhout, M. Treur, Angelika Mehnert et al. · Journal of Medical Economics · 2015 · 19 citations · Full text

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Hiroyo Kuwabara, K.Y. Westerhout, M. Treur et al. · Journal of Medical Economics · 2015 · 14 citations · Full text